Although loricrin is the predominant protein of the cornified envelope (CE) in keratinocytes, loss or gain of loricrin function in mouse models produces only modest skin phenotypes. In contrast, insertional mutations resulting in a frameshift in the C-terminal domain of loricrin produce the characteristic ichthyosis of loricrin keratoderma in mouse and man. To ascertain the basis for the loricrin keratoderma phenotype, we assessed epidermal structure and stratum corneum (SC) function in a previously genotyped human loricrin keratoderma kindred. Our studies revealed abnormal corneocyte fragility and basal permeability barrier function, but accelerated repair kinetics. Despite fragility, increased water loss occurred predominantly via extracellular domains, which correlated with disorganized lamellar bilayers that were linked spatially to discontinuities of the CE. Accelerated barrier recovery was explicable by amplified lamellar body secretion, while partial normalization of the CE in the outer SC correlated with persistence of abundant calcium in the extracellular spaces (positioned to activate transglutaminase-1). These results show that the barrier abnormality in loricrin keratoderma is linked to a defective CE scaffold, resulting in increased extracellular permeability, as shown previously for another ''scaffold disorder'', lamellar ichthyosis. But in contrast to lamellar ichthyosis, the CE scaffold partially normalizes in the outer SC in loricrin keratoderma.
1998; Ishida-Yamamoto and Iizuka, 1998; Takahashi et al, 1999; O'Driscoll et al, 2002) . Clinically, loricrin keratoderma exhibits a characteristic, honeycomb-like, palmo-plantar keratoderma; generalized fine-scaling; hyperkeratotic knuckle pads on the dorsal surface of the fingers; and constricting bands encircling the fingers and/or toes (pseudoainhum) (Vohwinkel, 1929; Camisa and Rossana, 1984; Camisa et al, 1988; Maestrini et al, 1996; Armstrong et al, 1998; Takahashi et al, 1999; O'Driscoll et al, 2002) . Whereas insertional mutations that result in aberrant, elongated C-terminal domains of one loricrin allele are found in loricrin keratoderma (Maestrini et al, 1996) , another hyperkeratotic skin disorder, keratoderma hereditaria mutilans (syn. classical Vohwinkel disease, OMIM # 124500) as originally described in 1929 by Vohwinkel is caused by mutations in connexin 26, and is associated with deafness in addition to palmo-plantar keratoderma, but without generalized scaling (Korge et al, 1997; Maestrini et al, 1999) .
To better understand the link between the loricrin genotype and the skin pathology in loricrin keratoderma, several murine models have been developed with either loss or gain of loricrin function (Koch et al, 2000; Suga et al, 2000) . Although overexpression of human loricrin in transgenic mice does not yield an abnormal skin phenotype (Yoneda and Steinert, 1993) , loricrin deficiency in knockout mice results in delayed SC development in utero, and erythematous, shiny, translucent skin at birth, which largely resolves by the fourth to fifth postnatal day (Koch et al, 2000) . Normalization of the skin phenotype is attributable to increased compensatory expression of members of the SPRR family and repetin (Koch et al, 2000; Steinert, 2000) . Despite a lack of L-granules, CE structure in these animals appears largely normal (Jarnik et al, 2002) . In contrast, mice that recapitulate the C-terminal modification, as in human loricrin keratoderma, display a persistent skin phenotype that mimics the human disease (i.e., generalized scaling), which develops within the first 3 d of postnatal life, constricting bands encircling the tail, and thickening of foot pads (Suga et al, 2000) . In these mice, the mutant loricrin appears to be retained in the nuclei of the SG and SC layers, and fails to reach the CE (Suga et al, 2000) . The relationship between the aberrant localization of the mutant loricrin and the phenotypic features of loricrin keratoderma remains unclear. Although dominant/negative interference of the mutant with the wild-type polypeptide has been proposed (Maestrini et al, 1996) , alternatively, insufficient amounts of intact protein (haploinsufficiency) could account for the phenotype. Regardless of the precise molecular mechanism, we hypothesized that abnormal SC structure is an important pathophysiologic feature of loricrin keratoderma, resulting in an exaggerated hyperplasia, which may be secondary to a barrier abnormality.
Accordingly, abnormal epidermal permeability barrier function was reported in mice with the murine mimic of human loricrin keratoderma (Suga et al, 2000) . Barrier abnormalities have been noted in a number of ichthyoses associated with structural protein abnormalities. For example, transglutaminase-1 mutations result in a barrier abnormality in lamellar ichthyosis (Ghadially et al, 1992; Lavrijsen et al, 1993; Elias et al, 2002) , and barrier abnormalities also occur in mice with deletion of this enzyme (Matsuki et al, 1998; Kuramoto et al, 2002) . In addition, mutations in keratins 1 or 10 in epidermolytic hyperkeratosis are accompanied by a barrier abnormality (Schmuth et al, 2001b) . Human loricrin keratoderma, should it also display a permeability barrier abnormality, as does the murine mimic (Suga et al, 2000) , would provide a valuable model to test the role of the major protein constituent of the CE in epidermal permeability barrier function. To dissect the pathogenesis, we assessed first, the range of functional abnormalities present in a large kindred of previously genotyped patients with loricrin keratoderma (Maestrini et al, 1996) . Involved skin demonstrated a marked increase in basal water loss (TEWL), an accelerated repair response following acute perturbations, reduced hydration, and cohesion as well as increased skin fragility in most subjects. Despite evidence of increased fragility, lanthanum tracer studies showed that the permeability barrier abnormality in loricrin keratoderma is attributable predominantly to increased extracellular, rather than transcellular, movement of water. An attenuated CE explains both increased corneocyte fragility, and the marked disorganization of the extracellular lamellar bilayer system (scaffold abnormality), leading to increased transcutaneous water loss. Yet, partial normalization of the CE abnormality in the outer SC probably accounts for the relatively mild clinical phenotype in loricrin keratoderma versus another CE scaffold disorder, lamellar ichthyosis.
Results
Loricrin keratoderma subjects display abnormal epidermal barrier function, hydration and SC cohesion We had an opportunity to evaluate not only the originally described subjects (Maestrini et al, 1996) , but also additional members of the kindred (Tables S1 and S2 ). We first assessed basal permeability barrier function over two separate, non-sunexposed body sites of subjects and controls, representing the two principal loricrin keratoderma skin phenotypes; i.e., volar wrist skin (honeycomb-like hyperkeratotic changes), and proximal volar forearm (fine-scaly ichthyosis). Over the wrist area, basal TEWL rates were markedly increased, with a mean of 24.9 g per m 2 per h in subjects versus 8.8 g per m 2 per h (po0.05) over the same site in unrelated control subjects ( Fig 1A) . Basal TEWL rates also were increased over the volar forearm area, with a mean of 12.1 g per m 2 per h in patients versus 6.9 g per m 2 per h (po0.05) in unrelated, normal control subjects over the same location ( Fig 1A) . Loricrin keratoderma subjects also displayed other functional abnormalities, including markedly reduced SC hydration in the hyperkeratotic/honeycomb-type skin sites. Furthermore, the surface pH of the SC showed a trend towards being more acidic in loricrin keratoderma than in control subjects, but the difference did not achieve statistical significance (Fig 1C) .
We next compared the SC response to acute abrogation mechanical stress in affected versus control subjects. When the permeability barrier was experimentally perturbed by tape stripping to a maximal 4TEWL 2-fold higher than basal levels, SC cohesion was markedly reduced in loricrin keratoderma as determined by measurement of the amount of protein removed per tape strip (Fig 1D) . Surprisingly, severely affected loricrin keratoderma demonstrated super normal recovery response after tape stripping if compared to control subjects at 3 and/or 6 h (Fig 2) . These results show that loricrin keratoderma subjects, despite a prominent basal barrier abnormality and decreased SC cohesion, exhibit accelerated barrier recovery kinetics after acute barrier disruption.
Basis for skin fragility in loricrin keratoderma On histology, biopsies from loricrin keratoderma revealed the previously described characteristics, including epidermal hyperplasia, hypergranulosis, marked hyperkeratosis, and parakeratosis with characteristic roundish nuclei in the lower SC as described previously (Maestrini et al, 1996; Korge et al, 1997) . In contrast, biopsies from unaffected family members displayed a normal epidermis, with an orthokeratotic SC, indistinguishable from normal skin (notshown). In most loricrin keratoderma samples, we observed an additional, previously unrecognized feature; i.e. a plane of decreased tissue integrity within or just above the outermost granular (SG) layer (Fig 3, arrows) , with an enhanced propensity for tissue samples to sheer either with sectioning or with physical manipulation. On electron microscopy, the cleavage plane could be further shown to pass both through and between cells in the outer SG layer and at the SG-SC interface (Fig 3) . Together, these results demonstrate a zone of decreased tissue integrity in the outer nucleated layers of the epidermis in loricrin keratoderma.
To determine whether this morphologic evidence of compromised integrity correlated with increased skin fragility, we used the pencil eraser test, applying controlled torque and downward pressure to loricrin keratoderma versus control sites (Williams and Elias, 1981a, b) . We observed an increased tendency for the SC to shear off (subcorneal disadherence) in a majority of tested loricrin keratoderma subjects (''pseudo-Nikolskij'' sign) (Grando et al, 2003) , (Table S1 ) a clinical feature that has not been tested previously in loricrin keratoderma, whereas five similarly treated, control subjects exhibited no such tendency. Yet, it should be noted that loricrin keratoderma subjects did not report an increased tendency for symptoms attributable to excess skin fragility. Accelerated barrier recovery kinetics accelerate in loricrin keratoderma. Barrier recovery was assessed as % change in transepidermal water loss 3 and 6 h after acute barrier disruption of lorcrin keratoderma severely affected (distal, n ¼ 8) versus mildly affected (proximal, n ¼ 2) skin sites by tape stripping, and normal control skin sites.
To ascertain whether increased fragility results from alterations in the outer SG layers or impaired resiliance of the SC to chemical disruption, we next assessed CE structures after boiling of loricrin keratoderma versus control scale samples in SDS/DTT, as previously employed to assess corneoycyte competence in lamellar ichthyosis (Jeon et al, 1998; Elias et al, 2002) . Although lamellar ichthyosis scale is readily disrupted by this treatment (vida supra), loricrin keratoderma scale (outer SC) remains intact after boiling in SDS and DTT, comparable to control scale (not shown). These results further show that, despite evidence of enhanced fragility in the SG, the outer SC in loricrin keratoderma becomes competent.
Abnormal barrier function in loricrin keratoderma is attributable to increased cellular permeability Utilizing colloidal lanthanum as a tracer to localize sites of enhanced water movement, we next assessed whether the basal barrier abnormality in loricrin keratoderma could be attributed to enhanced inter-versus trans-cellular movement of water; i.e., due to porous extracellular domains versus defective corneocytes. Prior studies have shown that lanthanum is excluded from normal SC (Wolff and Schteiner, 1968; Elias et al, 1977 Elias et al, , 1981 Elias et al, , 1984 Elias et al, , 2002 Williams and Elias, 1981a, b; Schmuth et al, 2001b) , which was again shown here in unaffected subjects and normals (not shown). In contrast, lanthanum tracer penetrated bidirectionally deep into the SC in biopsies from loricrin keratoderma (Figs 4A-C). Although most of the electron-dense tracer appeared within the extracellular spaces, small amounts of tracer leaked into the peripheral cytosol of some corneocytes ( Fig  4B) , consistent with some water movement into abnormally fragile corneocytes. Despite evidence of decreased epidermal integrity, however, water movement across SC in loricrin keratoderma occurs primarily via the extracellular pathway.
Abnormal CE structure accounts for the extracellular barrier abnormality To assess further the basis for increased extracellular permeability of the SC in loricrin keratoderma, we next determined whether the CE scaffold is abnormal, as in lamellar ichthyosis (Elias et al, 2002) . CE structures in the lower SC appeared markedly attenuated in loricrin keratoderma versus control biopsy samples, as reported previously (Korge et al, 1997) , and displayed frequent discontinuities . To assess whether the attenuated CE in the lower SC of loricrin keratoderma reflect decreased loricrin deposition, we next assessed loricrin distribution by immunohistochemistry. As reported previously (Maestrini et al, 1996; Korge et al, 1997) , loricrin deposition was decreased in CE from loricrin keratoderma versus control subjects as assessed with an antibody raised against the C-terminus (not shown). Quantitative studies, performed by a blinded observer on coded micrographs (see Materials and Methods), confirmed a reduced thickness of CE in the lower SC of loricrin keratoderma versus CE in both unaffected relative and reported values for normal CE (White et al, 1996) (Fig 7) , in contrast to the normal thickness in loricrin knockout mice when measured on freeze-isolated dried CE (Jarnik et al, 2002) . However, in our human loricrin keratoderma skin samples CE thickness partially normalized (to about 2/3 normal thickness) in the outer SC (5.76 AE 1.01 vs 8.81 AE 0.24 nm; po0.05). In the insert of Fig first, a marked CE scaffold abnormality in the lower SC in loricrin keratoderma; and second, they further support the hypothesis that peptide precursors, other than loricrin, continue to be cross-linked into CE during apical migration from the lower to the upper SC.
Despite evidence of attenuated CE in the lower SC, CLE ultrastructure appeared normal at all levels of SC in loricrin keratoderma (Figs 5A, 6C-D; 5B and 6A ¼ normal). These morphological studies were further confirmed by biochemical studies, which showed that neither the total bound o-OH-ceramide content nor its subfractions, o-OH-ceramide A or o-OH-ceramide B, differed in loricrin keratoderma versus normal (sunburn) scale (Table I ). There was a statistically significant decrease, however, in free o-OH fatty acids in SC from loricrin keratoderma, consistent with impaired lipid processing of o-OH Cer into o-OH FA by ceramidase. Together, these results demonstrate an altered CE, but largely normal CLE structure and composition in loricrin keratoderma.
Extracellular lamellae are abnormal in loricrin keratoderma Two unrelated structural abnormalities could account for increased extracellular permeability in loricrin keratoderma: (1) the abnormal CE scaffold could lead to altered lamellar bilayer organization; or (2) the mutant loricrin could interfere with LB secretion, leading to a paucity of secreted LB contents. In examining the first possibility, extracellular lamellar bilayer organization, as assessed in RuO 4 post-fixed tissue, was abnormal in all loricrin keratoderma samples (Fig 6B and C) . Relatively normal-appearing membrane arrays alternated with foci characterized by irregularly configured, loosely organized, or fragmented lamellar bilayers (Fig 6B and C, asterisks) . Furthermore, consistent with biochemical evidence of delayed lipid processing (Table I) , stacks of incompletely processed membranes persisted well above the SG-SC interface (Fig 6D, solid arrows) . Biopsies from proximal sites with milder disease exhibited the same features as did biopsies from acral sites, but in less exaggerated form (Fig 6C vs B) . Together, these results show that abnormalities in extracellular membrane structure correlate with the basal permeability barrier abnormality in loricrin keratoderma.
LB secretion is largely normal in loricrin keratoderma We next explored whether increased extracellular water movement in loricrin keratoderma could also be attributable, in part, to cytoskeletal alterations that interfere with LB secretion, as occurs in epidermolytic hyperkeratosis (Schmuth et al, 2001) . In all patient biopsies we observed: (a) normal quantities of secreted extracellular lamellae; consistent with unimpeded secretion (Fig 6A-C) ; (b) a normal density of LB, with replete internal contents, in the upper spinous and SG layers (not shown); (c) largely normal amounts of secreted LB contents at the SG-SC interface (Fig 6, asterisks) ; and (d) relatively little, entombed LBderived, lamellar material in the corneocyte cytosol (Fig 6B-D , double arrows). Whereas these results suggest that LB assembly and secretion are unimpaired in loricrin keratoderma, we further determined LB secretion competence by assessing the distribution of an enzyme cytochemical marker of LB contents; i.e., acid lipase (Menon et al, 1986) . LB-derived hydrolase contents were regularly delivered into the SG-SC interface, with little residual, detectable activity within the corneocyte cytosol in loricrin keratoderma (Fig 8) . Together, these results show that LB secretion is largely unimpaired, and therefore, that a cytoskeletal abnormality does not explain the barrier defect in loricrin keratoderma.
Accelerated LB secretion with normalized lipid processing account for rapid recovery kinetics We next assessed the structural basis for the accelerated barrier recovery response in loricrin keratoderma. Biopsies from affected versus unaffected family members and normal human skin were obtained both 3 and 6 h after tape stripping, when loricrin keratoderma recovery kinetics markedly accelerate (cf. Fig 2) . As reported previously (Menon et al, 1992a) , in control samples, LB formation and secretion increased over basal rates after tape stripping, but secretion remained restricted to the SG-SC interface (not shown). In contrast, in patient samples secretion began in the lower SG, and continued at all levels of the granular layer (Fig 9B and D) . As a result, there were increased quantities of secreted lamellar bilayers in some foci (Fig 9A) . Moreover, lipid processing largely normalized (i.e., there was little or no unprocessed, secreted LB contents above the SG-SC interface (Fig 9D; cf. Fig 6D) . These results show that accelerated barrier recovery in loricrin keratoderma is paralleled by an amplified LB secretory response. Persistence of membrane-associated calcium correlates with normalization of CE in outer SC Prior studies have shown that changes in the calcium (Ca 2 þ ) gradient in vivo regulate LB secretion (Lee et al, 1992) , and that modulations in extracellular Ca 2 þ in vivo also regulate keratinocyte differentiation (Elias et al, 2000b) . To determine whether the accelerated LB secretion in loricrin keratoderma after acute disruption reflects modulations in the epidermal Ca 2 þ gradient, we employed ion capture cytochemistry, as described previously (Menon et al, 1985) . In basal samples, we observed normal levels of extra-and intracellular Ca 2 þ in the outer SG cells in loricrin keratoderma, but in contrast to healthy control SC, substantial Ca 2 þ persisted into the SC in loricrin keratoderma SC, a minimal occurrence in normal human skin (Fig 10A vs B) . In the lower layers of loricrin keratoderma SC, Ca 2 þ frequently appeared within the corneocyte cytosol (Fig 10A) , a finding that correlated with the occasional leakage of lanthanum into corneocytes (cf . Fig 4) . But in the outer layers of loricrin keratoderma SC, Ca 2 þ localizes primarily to membrane domains (Fig 10A,  arrows) . These results show first that the increased LB secretory response after acute barrier disruption is not attributable to qualitative alterations in the epidermal Ca 2 þ gradient. Second, the persistence of substantial Ca 2 þ into the SC, with further localization to membrane domains, correlates with partial normalization of CE morphology in the outer SC of loricrin keratoderma, presumably catalyzing ongoing transglutaminase-1 activity.
Discussion
The cutaneous permeability barrier resides in the SC, which consists of extracellular lipid bilayers (mortar), mediating the permeability barrier against excess water and electrolyte loss, and a protein component, the corneocyte (bricks), which provides mechanical resistance to the SC, and simultaneously, a scaffold for the supramolecular organization of the extracellular lamellar bilayers (Jackson et al, 1993) . Disorders of cornification can be due to a defect in either of the two components. Our laboratories have previously assessed the basis for the permeability barrier abnormality and the ichthyosiform skin phenotype in a variety of disorders of cornification (Williams, 1991) . The barrier abnormalities in disorders, such as recessive x-linked ichthyosis, essential fatty acid deficiency, Refsum's disease, and Sjö gren-Larssen syndrome, results from changes in extracellular membrane architecture due to discrete lipid biochemical defects (Williams and Elias, 1981b, 1985) . More recently we have begun to assess the Scale samples were assessed from ten loricrin keratoderma and three normal subjects (normal sunburn scale data from Elias et al (2002) . Standards used for quantitative TLC were C24:0 (lignoceric acid), and a-hydroxyacylsphingosine (Sigma, St. Louis, MO). o-OH Cer A contains a sphingosine base, whereas o-OH Cer B contains a hydroxysphinganine base (Jarnik et al, 2002) . basis for permeability barrier abnormalities in ichthyoses associated with structural protein abnormalities. There is evidence that although corneocyte structural proteins are known to provide mechanical resilience to the SC, defects in certain corneocyte structural proteins also can lead to permeability barrier abnormalities (Ghadially et al, 1992; Matsuki et al, 1998; Elias et al, 2000a Elias et al, ,b, 2002 Koch et al, 2000; Suga et al, 2000; Schmuth et al, 2001b; Kuramoto et al, 2002) . The studies further demonstrate that deficiencies in corneocyte proteins alter permeability barrier function by a variety of mechanisms. For example, transglutaminase-1 mutations produce defects in the CE/ CLE scaffold that account for the minor barrier abnormality both in lamellar ichthyosis (Ghadially et al, 1992; Lavrijsen et al, 1993; Elias et al, 2002) , and in mice with deletion of this enzyme (Matsuki et al, 1998; Kuramoto et al, 2002) . A defective scaffold also presumably accounts for the minor barrier abnormality in involucrin knockout mice 1 , that otherwise display a grossly normal phenotype (Djian et al, 2000) . In contrast, mutations in keratin 1 or 10 in epidermolytic hyperkeratosis provoke a barrier abnormality by interfering with LB exocytosis (cytoskeletal, rather than scaffold abnormality) (Schmuth et al, 2001b) . A third, unrelated mechanism whereby corneocyte abnormalities can provoke a permeability barrier abnormality is exemplified by retinoid treatment, which results in attenuated corneocytes that allow increased transcellular water movements (Williams and Elias, 1981a) .
In this study, we assessed the consequences of mutations in the major CE constituent, loricrin, on epidermal function and epidermal morphology by studying skin from patients, which have previously been genotyped for mutations in the loricrin gene (Maestrini et al, 1996) . We identified functional abnormalities in SC hydration, cohesion, and a marked permeability barrier abnormality. Hence, our studies aimed at delineating the pathophysiologic link between the loricrin mutation in our patients and the barrier abnormalities. First, our observations underscore the presence of an increased fragility of corneocytes in this disease. We observed a plane of decreased tissue integrity within the outermost granular layer (Fig 3) . Decreased tissue integrity within this plane, however, did not result in overt clinical signs of increased skin/SC vulnerability; i.e., patients did not report increased blister formation or susceptibility to injury. One possible explanation is that compensatory overexpression of other CE proteins (Koch et al, 2000; Steinert, 2000; Jarnik et al, 2002) , appears to normalize CE structure in the outer SC of loricrin keratoderma, thereby reducing corneocyte fragility. Nevertheless, we observed an impaired mechanical resilience of the SC to torque and downward pressure in a majority of the affected subjects tested (Table  S1) , presumably due to a decrease in epidermal integrity. The basis for abnormal fragility at the level of the outer nucleated layers of the epidermis remains unknown. It is possible that either mutant loricrin or the lack of normal loricrin could disrupt the cytoskeleton. Alternatively, loricrin deposition into the CE normally begins at the level of the outer granular layer, and the failure of mutant loricrin to translocate from the nucleus (Koch et al, 2000; Suga et al, 2000) could compromise the integrity of cell membrane in the outer nucleated layers of the epidermis.
CE structures in the lower SC were both markedly attenuated (about 30% of normal thickness, Fig 7) and discontinuous (Fig 5) in patient versus control biopsy samples. Yet, quantitatively the CE eventually attained dimensions that were about 2/3 of normal thickness in the outer SC. These observations probably explain why loricrin keratoderma, in contrast to lamellar ichthyosis, scale, is resistant to boiling in SDS and DTT, as is SC from normal subjects. We would hypothesize further that the resiliance of loricrin keratoderma scale to SDS/DTT treatment likely reflects the assembly of other precursor proteins into the CE, due to ongoing activity of transglutaminase-1, a process that would be impaired in lamellar ichthyosis, even in the presence of abundant Ca 2 þ (Fig 11) . Low rates of cross-linking into the CE are known to occur during the transit of corneocytes from the inner to the outer layers even in normal SC (Michel et al, 1988) . Cross-linking may be restricted in normals by the low levels of Ca 2 þ , in normal SC (Menon et al, 1985) , which are required for transglutaminase-1 catalytic activity (Rice and Green, 1979) . In contrast, the presence of substantial Ca 2 þ in loricrin keratoderma SC (Fig 10) , and more specifically in membrane domains, would favor on-going activity of 
Figure 11
Theoretical basis for different scaffold abnormalities in loricrin keratoderma versus lamellar ichthyosis (LI). (A) In loricrin keratoderma (1), mutant loricrin does not incorporate into cornified envelope (CE), but other CE precursors incorporate progressively into CE due to persistence of Ca 2 þ , as well as ongoing transglutaminase-1 activity. In LI (2), such compensation cannot occur because of decreased transglutaminase-1 activity.
co-localized transglutaminase-1 within the CE. The basal barrier abnormality in loricrin keratoderma, in turn, accounts for elevated Ca 2 þ levels in the SC, because a similar translocation of Ca 2 þ into the SC is seen in other chronic dermatoses, characterized by a barrier abnormality Menon et al, 1994) .
In this study, we report for the first time that the ichthyosiform dermatosis in human loricrin keratoderma is accompanied by a marked permeability barrier defect, and that this functional defect can be attributed to abnormalities in SC extracellular lamellar membrane structure. In loricrin keratoderma subjects, lamellar bilayers were irregularly configured, loosely organized, and/or fragmented, with stacks of incompletely processed membranes interspersed among normal-appearing, intact bilayers, features that all were even more prominent in biopsies from acral (severely involved) areas. Yet, permeability barrier repair kinetics accelerate in loricrin keratoderma, a finding that is not explicable by the abnormal CE scaffold and the abnormal extracellular membrane structures. LB morphology and secretion appear normal under baseline conditions, and appear to accelerate following acute barrier disruption in loricrin keratoderma. This hyperactive LB-secretory response results in rapid replenishment of most of the extracellular spaces (Menon et al, 1992a) . As a result lipids rapidly reaccumulate within the SC extracellular spaces after acute disruption, with accelerated reformation of (abnormal) membrane bilayers, and restoration of basal, but still-abnormal barrier function in loricrin keratoderma. The basis of this accelerated repair response remains unknown since they did not correlate with qualitative alterations in the epidermal Ca 2 þ gradient (Fig 10) . Together, these studies suggest that CE scaffold abnormalities result in a markedly abnormal SC barrier under basal conditions in human loricrin keratoderma, and that this abnormality is due to distorted extracellular lamellae. Yet, the LB secretory machinery is perennially upregulated, presumably in compensation for the basal abnormality, resulting in accelerated repair kinetics after acute insults.
Primary disorders of lipid metabolism, which alter the extracellular (mortar) domains, inevitably are accompanied by permeability barrier abnormalities (Williams, 1991) . Because the permeability barrier to water and electrolyte movement resides in the extracellular, rather than in the corneocyte (brick), compartment of the SC, it is not immediately obvious why abnormalities in corneocyte proteins; i.e., loricrin in loricrin keratoderma, keratins 1 and 10 in epidermolytic hyperkeratosis and transglutaminase-1 in lamellar ichthyosis produce permeability barrier abnormalities (Elias et al, 2002; Schmuth et al, 2001b) . Moreover, perturbation/removal of the extracellular lipids by solvent or detergent treatment alone, without affecting the corneocytes, results in complete disruption of the permeability barrier, as indicated by a massive increase in TEWL (Scheuplein and Morgan, 1967 ). Yet, all human hereditary disorders with corneocyte defects that have been studied to date including loricrin keratoderma studied here, display marked abnormalities in the quantities, morphology, and/or organization of extracellular lipid bilayer system. Together, these observations underscore the role of the corneocyte and its constituent proteins as a scaffold that is critically required for the normal organization of extracellular lipid bilayers. Accordingly, loricrin, which normally provides up to 80% of the protein content to the CE, if mutated as in human loricrin keratoderma, results in effete CE, ultimately leading to abnormal organization of the lamellar bilayers and a defect in SC extracellular permeability barrier.
Materials and Methods
Patients Sixteen patients (eight females, eight males, aged 11-79 y) with clinically typical loricrin keratoderma (Table S1 ) consented to participate in these studies (protocol approved by UCSF Committee on Human Research). All patients were members of a large, previously described, and genotyped kindred (Maestrini et al, 1996) . 15 patients were evaluated by functional studies, fullthickness skin biopsies were obtained from five of these subjects (two females, three males, aged 25-69 y) and scale was obtained from 11 patients (6 females, 5 males, aged 11-79 y) (Table S2 ). Skin from five unaffected members of the same kindred (two females, three males, aged 10-71 y), as well as six unrelated, age-and sexmatched subjects without skin disease (four females, two males, aged 21-47 y), comprised the two control groups. All affected subjects displayed hyperkeratosis of palms, soles, and dorsum of feet, extending proximally onto the wrists and ankles, with a characteristic honeycomb appearance. Moreover, all affected subjects also showed generalized fine scaling of mild-to-moderate severity. In addition, some, but not all, affected individuals showed variable, mild erythroderma, pruritus, hyperkeratosis of the knuckle pads on the dorsal surface of the fingers, and nail dystrophy (Table S1 ). Furthermore, several affected subjects either showed a tendency for, or already had developed constricting bands of the fourth and/or fifth digits of their hands and/or feet (pseudoainhum), which had progressed in one subject to autoamputation of a digit.
Functional studies To assess epidermal permeability function we measured TEWL over two separate sites; i.e., the wrist area (honeycomb-like changes) and the volar forearm (fine-scaling ichthyosis), in all loricrin keratoderma and control subjects using a Tewameter (TM 210; Courage & Khazaka, Cologne, Germany). Volunteers each underwent at least 15 min pre-assessment rest period, and measurements were taken after further equilibration of the probe on the skin surface. Environment-related variables at the time of the study were: ambient air temperature 211C-241C; skin surface temperature 30.81C-331C, ambient air humidity 58%-66%. TEWL was measured both under basal conditions, as well as following acute barrier disruption by repeated cellophane tape stripping (to TEWL 42 mg per cm 3 per h). Barrier recovery kinetics then were assessed by measuring TEWL at 3 and/or 6 h after acute disruption. For calculation of the percent change in TEWL, the following formula was used: {(TEWL stripped area at indicated time/TEWL control area at indicated time)/(TEWL stripped area before stripping/TEWL control area before stripping)À1} Â 100%. Surface pH was measured using a Skin-pH-Meter (PH900; Courage & Khazaka), equipped with a flat glass electrode (Mettler-Toledo, Giessen, Germany). SC hydration was assessed as changes in electrical capacitance (absolute units) with a Corneometer (CM 825; Courage & Khazaka) . Finally, in ten loricrin keratoderma subjects (6 females, 4 males, aged 11-79 y), SC fragility was assessed clinically by application of controlled friction (torque) with slight pressure, by rotating a new pencil eraser on the skin surface as described previously (Williams and Elias, 1981a) (''pseudo-Nikolskij'' sign according to Grando et al, 2003) .
SC cohesion was assessed as protein removed per D-Squame strip. Before stripping the SC, the skin surface was cleaned with a single ethanol wipe. D-Squame tapes then were placed sequentially to the test areas for about 3 s each, removed with the forceps, and stored in glass scintillation vials at 51C. The amount of protein removed per D-Squame was measured, by a modification of the method of Dreher et al (1998) . The protein content per stripping was determined with the Bio-Rad Protein Assay Kit (Biorad, Hercules, CA). Lyophilized, bovine g globulin was used as the standard in all assays. Each tape was incubated with 1 mL of 1 M NaOH for 1 h at 371C in a shaker and neutralized thereafter with 1 mL of 1 M HCl in the scintillation vials. Subsequently 0.2 mL of this solution was incubated in 0.6 mL distilled water plus 0.2 mL of the Bio-Rad protein dye for 5 min in borosilicate tubes. After incubations, the reagents were transferred to polysterene cuvettes, and absorption was measured with a Genesys 5 spectrophotometer (Spectronic, Rochester, New York) at 595 nm. An empty DSquame tape, as well as distilled water incubated with the Bio-Rad dye, served as negative controls. The amount of calculated protein was then normalized to skin surface area (mg per cm 2 ).
Biopsies and assessment of CE fragility Biopsies from loricrin keratoderma and control skin sites were taken immediately before, 3 and/or 6 h after acute barrier disruption (Table S2 ). To further assess SC fragility, tissue blocks were pre-sectioned using a scalpel blade, examined for clefts under a dissecting microscope, and photomicrographs were taken using a Nikon Microphot-FX camera (Nikon Inc., Melville, New York) in the dark-field mode. To assess whether increased corneocyte fragility can be attributed to a defective CE, we isolated CE from loricrin keratoderma and control scale samples (sunburn), as described recently (Elias et al, 2002) . Isolated scale was placed in 2% SDS and 20 mM dithiothreitol (DTT) in 50 mM Tris buffer, and boiled for 5 min. After centrifuging (1000 Â g Â 10 min), CE suspensions were assessed by light microscopy in the Nomarsky mode (Jeon et al, 1998) .
Histology and immunohistochemistry Skin sections (6 mm) were fixed in 4% formaldehyde, embedded in paraffin, stained with hematoxylin & eosin and photographed with an Axiovision 2 Imaging Zeiss light microscope (Jena, Germany), using Axiovision software (Munich, Germany). For immunohistochemistry, paraffin sections (6 mm) were incubated for 30 min in blocking buffer (1% bovine serum albumin, 0.1% cold water fish gelatin in phosphatebuffered saline, PBS) and then incubated for 2 h at room temperature with a primary rabbit antibody against the C-terminus (HQTQQKQAPTWPCK) of loricrin (BabCo, Richmond, California), diluted (1:500) in blocking buffer. Tissue sections were washed with PBS and incubated for 1 h at room temperature with a goat antirabbit antibody (Vector Labs, Burlingame, California), and diluted in blocking buffer. Tissue sections then were washed with PBS and coverslipped before visualization under a confocal microscope (Leica TCS SP, Heidelberg, Germany) at an excitation wavelength of 488 nm and an emission wavelength of 518 nm.
Ultrastructural studies
Approach To assess the morphological basis for the barrier abnormality in patients with loricrin mutations, we employed an algorithmic sequence similar to that recently applied to Harlequin ichthyosis (Elias et al, 2000b) , epidermolytic hyperkeratosis (Schmuth et al, 2001b) , and lamellar ichthyosis (Elias et al, 2002) . Since permeability barrier function was abnormal, we initially assessed the ultrastructural morphology of the CE/CLE corneocyte scaffold. Then, using the water-soluble, low molecular weight tracer, colloidal lanthanum (Williams and Elias, 1981a) , we determined whether the permeability abnormality is due to leaky corneocytes, resulting in increased transcellular water movement (fragility), or to enhanced intercellular permeability (scaffold) (normal SC excludes lanthanum movement). When permeability occurs predominantly via an intercellular route (as it did here), we then assessed extracellular lamellar bilayer quantities and their supramolecular organization. Finally, LB morphology and the extent of LB secretion were assessed to determine whether the mutant protein interferes with secretion of LB contents.
Assessment of permeability pathway by lanthanum perfusion The perfusion pathway was assessed by immersion of loricrin keratoderma biopsies and/or scale in 4% lanthanum nitrate in 0.05 M Tris buffer, pH 7.4, containing 2% glutaraldehyde and 1% paraformaldehyde for 1 h at room temperature (Elias et al, 2002; Schmuth et al, 2001b) . After lanthanum perfusion, the samples were washed and processed for electron microscopy, as described below.
Assessment of cornified envelope-associated structures Using a combination of osmium (OsO 4 ) and ruthenium tetroxide (RuO 4 ) post-fixation with pyridine pre-treatment, it is possible to assess the integrity of the intercellular lamellar bilayer system in relation to the CE/CLE scaffold (Elias, 1996; Elias et al, 2000b) . Skin samples, minced to o0.5 mm 3 each, were pre-fixed in halfstrength Karnovsky's fixative, followed by post-fixation in reduced 1% OsO 4 or 0.2% RuO 4 , as modified by Hou et al (1991) . Whereas RuO 4 post-fixation allows visualization of extracellular lamellar bilayer substructure and organization, for visualization of the CE/CLE membrane complex, parallel samples then were immersed for 2 h in absolute pyridine, as described recently (Elias et al, 2000b (Elias et al, , 2002 , and processed further as described below. All OsO 4 and RuO 4 post-fixed samples were dehydrated in a graded ethanol/propylene oxide series, and embedded in an Epon-epoxy mixture. Ultrathin sections assessed either unstained, or after further, lead citrate contrasting in a Zeiss 10A electron microscope operated at 60 kV (Zeiss, Ober Kochen, Germany).
Quantitation of CE dimensions Both biopsy and scale samples were soaked in absolute pyridine for 2 h, rinsed three times in 0.1 M cacodylate buffer, and then fixed in 1/2 strength Karnovsky's, followed by reduced osmium post-fixation and Epon embedding (as above). Samples were photographed at Â 31.5 and further enlarged Â 2 on a photocopier. Envelope thickness was measured randomly at every 0.5 cm point along CE in lower versus outer SC. At least 30 different areas were randomly photographed from each sample by an unbiased observer, and the mean AE SEM was calculated for patient versus control samples. A total of four loricrin keratoderma biopsies, three loricrin keratoderma scale samples, one control biopsy (unaffected family member), and three control scale samples from unrelated, sunburn patients were assessed.
Assessment of LB secretion To assess the LB secretory system, the following criteria were assessed: (a) amount of secreted material at the SG-SC interface (Menon et al, 1992a) ; (b) presence of ''entombed'' LB within the corneocyte cytosol (Schmuth et al, 2001) ; and (c) extent of extracellular delivery versus corneocyte retention of a lipid hydrolase (acid lipase), which is concentrated in LB, and normally secreted and segregated in toto within the SC interstices (Menon et al, 1986 (Menon et al, , 1992b Elias et al, 2002) . This method provides a useful indicator of retention of LB contents in disorders of cornification (Menon et al, 1992b; Schmuth et al, 2001b; Elias et al, 2002) . Aldehyde-pre-fixed samples were microwave-incubated with 0.2% Tween 85-containing substrate ( AE lipase inhibitor, tetrahydrolipstatin, 200 mM), a lead-capture, cytochemical method that depicts the localization of acidic and neutral lipases (Rassner et al, 1997 ). Samples for enzyme cytochemistry then were post-fixed in OsO 4 and processed, as above.
Ion capture cytochemistry The epidermal calcium gradient inversely regulates LB secretion in normal epidermis; i.e., accelerated secretion occurs in response to lowered extracellular calcium (Menon et al, 1985; Lee et al, 1992 ). An acute reduction in epidermal calcium explains the normalized kinetics of barrier recovery in epidermolytic hyperkeratosis after further acute abrogations of the barrier (Schmuth et al, 2001b) . For ultrastructural visualization of the epidermal calcium gradient, parallel biopsy samples from affected and unaffected controls were obtained both before and after acute barrier disruption (see above), fixed in 2% paraformaldehyde, 2% glutaraldehyde, 0.09 M potassium oxalate, containing 0.04 M sucrose overnight at 41C, and then post-fixed in 1% OsO 4 , containing 2% potassium pyroantimonate, pH 7.4, for were washed in alkalinized water (pH 10), and dehydrated in graded ethanol solutions, prior to embedding, as above.
Analysis of covalently bound ceramides Total lipid extracts were obtained from loricrin keratoderma and control scale, and covalently bound lipids were isolated by saponification of the exhaustively extracted samples, as described previously (Holleran et al, 1991) . Bound and unbound lipid extracts were quantitated after fractionation in a sphingolipid solvent system (Wertz et al, 1989; Elias et al, 2002) . Data were expressed as lipid fraction per mg protein, assessed on the post-saponification scale samples.
Statistics Statistical comparisons were performed using either paired or unpaired Student's t test, as appropriate. When three or more groups were compared, an ANOVA analysis was utilized. Statistical analyses were performed with Prism3 software (GraphPad, San Diego, California). Data are expressed as mean AE SEM. 
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